Literature DB >> 15941566

Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty rats.

Cyrus V Desouza1, Moira Gerety, Frederick G Hamel.   

Abstract

OBJECTIVE: Insulin resistance is associated with a constellation of factors that enhance the artherosclerotic process. Vessel injury results in the formation of a markedly increased neointima in type 2 diabetes. Increased neointimal hyperplasia (NH) and vascular endothelial growth factor (VEGF) expression may lead to restenosis post angioplasty. We studied NH and VEGF expression in an obese, insulin resistant, but normoglycemic rat model, after carotid balloon injury. METHODS AND
RESULTS: Diabetic rats (ZDF, n=10), normoglycemic, insulin-resistant rats (ZDF-normoglycemic, n=6) as well as Zucker fatty rats (FZ, n=6), and lean Zucker rats (LZ, n=6), all 13-16 weeks old, were subjected to right carotid injury by an angioplasty catheter introduced via the femoral artery. Three weeks later the rats were sacrificed and serum and carotids obtained. The intima-media ratio (I/M) was then calculated. ZDF-normoglycemic, FZ and ZDF-diabetic rats were all hyperinsulinemic and hypertriglyceridemic when compared to LZ rats. ZDF diabetic rats were hyperglycemic while FZ, ZDF-normoglycemic and LZ rats were normoglycemic. The I/M ratio for ZDF and FZ rats were significantly greater than for LZ rats. The VEGF expression was significantly greater in ZDF and FZ rats than LZ rats.
CONCLUSIONS: In conclusion, insulin resistance increases neointimal hyperplasia and VEGF expression even with normoglycemia, after carotid angioplasty in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941566     DOI: 10.1016/j.atherosclerosis.2005.04.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Role of metabolic environment on nitric oxide mediated inhibition of neointimal hyperplasia in type 1 and type 2 diabetes.

Authors:  Monica P Rodriguez; Zachary M Emond; Zheng Wang; Janet Martinez; Qun Jiang; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2013-12-12       Impact factor: 4.427

Review 2.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

3.  Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats.

Authors:  Subramanyam N Murthy; Cyrus V Desouza; Neal W Bost; Rose-Claire St Hilaire; David B Casey; Adeleke M Badejo; Jasdeep S Dhaliwal; Jennifer McGee; Dennis B McNamara; Philip J Kadowitz; Vivian A Fonseca
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

4.  Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.

Authors:  Sadaf S Ahanchi; Vinit N Varu; Nick D Tsihlis; Janet Martinez; Charles G Pearce; Muneera R Kapadia; Qun Jiang; Joseph E Saavedra; Larry K Keefer; Joseph A Hrabie; Melina R Kibbe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

5.  Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction.

Authors:  Cyrus V Desouza; Frederick G Hamel; Keshore Bidasee; Kelly O'Connell
Journal:  Diabetes       Date:  2011-02-23       Impact factor: 9.461

6.  Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet.

Authors:  Kouichi Miura; Hirohide Ohnishi; Naoki Morimoto; Shinichiro Minami; Mitsuaki Ishioka; Shunji Watanabe; Mamiko Tsukui; Yoshinari Takaoka; Hiroaki Nomoto; Norio Isoda; Hironori Yamamoto
Journal:  Cancer Sci       Date:  2019-01-09       Impact factor: 6.716

7.  The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats.

Authors:  Jianxin Lu; Jingzhang Ji; Howard Meng; David Wang; Bo Jiang; Lixin Liu; Edward Randell; Khosrow Adeli; Qing H Meng
Journal:  Cardiovasc Diabetol       Date:  2013-04-05       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.